Ivey Publishing

Product Details

Pfizer and the Challenges of the Pharmaceutical Industry (B) (Simplified Chinese Version)
Product Number:
9B19MC077
Publication Date:
12/12/2019
Revised Date:
07/31/2019
Length:
6 pages (4 pages of text)
Product Type:
Supplement
Source:
Ivey
Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.
Learning Objective:
After working through the assignment questions for Case B, students will be able to do the following:
  • Analyze how pharmaceutical companies strategically respond to changes in the industry.
  • Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).
  • Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.
  • Identify, analyze, and evaluate relevant data and information.
Issues:
Disciplines:
General Management/Strategy,  International
Industries:
Health Care Services
Setting:
United States, Large, 2018
Intended Audience:
Undergraduate/MBA
Price:
$3.15 CAD / $3.10 USD Printed Copy
$2.65 CAD / $2.62 USD Permissions
$2.65 CAD / $2.62 USD Digital Download
Associated Materials
Supplements: 9B19M077 (6 pages)
You Might Also Like...

Save In: